Wide Ranks

BTMD

Biote Corp.

6.68

Top Statistics
Market Cap 352 M Forward PE 7.18 Revenue Growth 12.80 %
Current Ratio 1.50 Trailing PE 22.27 Earnings Growth 37.50 %
Profit Margins 3.72 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 7.84 Enterprise / Revenue 1.58 Price To Sales Trailing12 Months 1.83
Profitability
Profit Margins 3.72 % Operating Margins 23.71 %
Balance Sheet
Total Cash 38 M Total Cash Per Share 1.17 Total Debt 122 M
Total Debt To Equity Current Ratio 1.50 Book Value Per Share -4.19
All Measures
Short Ratio 608.00 % Message Board Id finmb_1761348473 Shares Short Prior Month 881497
City Irving Uuid 3a4e632f-743f-325b-9f1b-1f1d5c1698e8 Previous Close 6.69
First Trade Date Epoch Utc 1 B Book Value -4.19 Total Debt 122 M
Volume 108503 Fifty Two Week Low 3.65 Total Cash Per Share 1.17
Total Revenue 193 M Shares Short Previous Month Date 1 B Target Median Price 9.68
Max Age 86400 Recommendation Mean 1.20 Sand P52 Week Change 0.3133
Operating Margins 23.71 % Target Mean Price 9.54 Net Income To Common 7 M
Short Percent Of Float 0.0386 Implied Shares Outstanding 52 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 239320 Average Volume10days 239320
Total Cash 38 M Next Fiscal Year End 1 B Revenue Per Share 5.77
Held Percent Insiders 0.2760 Ebitda Margins 20.22 % Trailing PE 22.27
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 6.69
Target Low Price 8.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 5.57
Open 6.74 Free Cashflow 37 M State TX
Dividend Yield 0.00 % Return On Assets 0.1816 Time Zone Short Name EST
Trailing Eps 0.3000 Day Low 6.52 Address1 1875 W. Walnut Hill Ln #100
Shares Outstanding 31 M Price Hint 2 Target High Price 11.00
Website https://biote.com 52 Week Change 0.3387 Average Volume 163465
Earnings Quarterly Growth 42.10 % Forward Eps 0.5800 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 100.40 % Is_sp_500 False
Regular Market Day High 6.78 Profit Margins 3.72 % Fifty Two Week High 8.44
Day High 6.78 Shares Short 825453 Regular Market Open 6.74
Industry Key medical-care-facilities Earnings Growth 37.50 % Enterprise To Revenue 1.58
Revenue Growth 12.80 % Shares Percent Shares Out 0.0265 Operating Cashflow 39 M
Currency USD Time Zone Full Name America/New_York Market Cap 352 M
Is_nasdaq_100 False Zip 75038 Quote Type EQUITY
Industry Medical Care Facilities Long Name biote Corp. Regular Market Day Low 6.52
Held Percent Institutions 0.6461 Current Price 6.68 Enterprise To Ebitda 7.84
Financial Currency USD Current Ratio 1.50 Gross Margins 70.05 %
Industry Disp Medical Care Facilities Number Of Analyst Opinions 5 Country United States
Float Shares 13 M Two Hundred Day Average 6.13 Enterprise Value 306 M
Price To Sales Trailing12 Months 1.83 Forward PE 7.18 Regular Market Volume 108503
Ebitda 39 M Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
biote Corp.

operates in practice-building business within the hormone optimization space.

It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.

The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.

It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female.

The company was founded in 2012 and is headquartered in Irving, Texas.